NEW YORK (GenomeWeb) – Beijing-based sequencing service provider Novogene announced today that it has received CLIA certification for its US clinical laboratory.
The lab is located within Novogene's sequencing center at the Sacramento campus of the University of California, Davis. The company opened the center in early 2016 to provide its US and global customers with whole-genome sequencing services for human, plant, and animal samples for biomedical and agricultural research.
"CLIA certification is an important milestone for Novogene, allowing us to provide genomic solutions not only for scientific research, but also for clinical testing," David Jiang, general manager of clinical and consumer genomic solutions at Novogene, said in a statement. "We are excited to offer our clinical partners high-quality sequencing services at low cost with fast turnaround time."
In addition to its facilities in China and the US, Novogene also operates a sequencing lab in Singapore.